Prevalence of Coronary Artery Diseases Among Adult Women Residents of Tehran: A Cross-Sectional Report From Tehran Cohort Study (TeCS).

Authors

Amirhossein Heidari, Nazila Heidari, Arash Jalali, Yekta Ghane, Zahra Lotfi, Akbar Shafiee, Farshid Alaeddini, Hamidreza Raeisi-Dehkordi, Saeed Sadeghian, Mohammadali Boroumand, Abbasali Karimi, Oscar H Franco

Published in

Cardiology research and practice. Volume 2026. Pages 1614045. Epub Aug 06, 2026.

Abstract

Coronary artery disease (CAD) is the leading cause of death worldwide. Among women, CAD is often underestimated, resulting in underdiagnosis and undertreatment. This study aimed to assess the prevalence of CAD and its risk factors in adult women, using data from the Tehran Cohort Study (TeCS).
We analyzed data from 4478 women with complete CAD information collected during the TeCS recruitment phase. The age-weighted prevalence of CAD was estimated using the 2016 national census data and previous CAD diagnoses. Logistic regression models were applied to identify factors independently associated with CAD in women.
The overall prevalence of CAD was 4.48% (mean age: 53.0 ± 12.37 years), with an age-weighted prevalence of 4.1% (95% CI: 3.1%-5.4%). Increasing age was strongly associated with CAD, with women aged ≥ 75 years showing markedly higher odds (OR: 11.94, 95% CI: 3.93-36.31, p < 0.001). Hypertension (OR: 2.58, 95% CI: 1.75-3.80, p < 0.001), hyperlipidemia (OR: 2.25, 95% CI: 1.55-3.24, p < 0.001), and diabetes mellitus (OR: 2.07, 95% CI: 1.49-2.88, p < 0.001) were also significant determinants of CAD. Older age groups exhibited a higher prevalence of CAD risk factors. Within the CAD group, a greater proportion of women had multiple comorbid risk factors compared with their non-CAD counterparts in the same age categories.
The prevalence of CAD and its associated risk factors among women in Tehran is substantial. These findings highlight the need for targeted preventive strategies to reduce CAD incidence in vulnerable female populations.

PMID:
42568848
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.